EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model

Azizur Rahman, Branislava Janic, Tasnim Rahman, Harshit Singh, Haythem Ali, Ramandeep Rattan, Mohsin Kazi iD, Meser M Ali

Cancers · 11.10.2023 · 15 (20) · 4931

DOI: 10.3390/cancers15204931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 11.10.2023. Verfasst von Azizur Rahman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC), as one of the most aggressive forms of breast cancer, is characterized by a poor prognosis and a very low rate of disease-free and overall survival. In recent years, immunotherapeutic approaches targeting T cell checkpoint molecules, such as cytotoxic lymphocyte antigen-4 (CTLA-4), programmed death1 (PD-1) or its ligand, programmed death ligand 1 (PD-L1), have shown great potential and have been used to treat various cancers as single therapies or in combination with other modalities. However, despite this remarkable progress, patients with TNBC have shown a low response rate to this approach, commonly developing resistance to immune checkpoint blockade, leading to treatment failure. Extracellular acidosis within the tumor microenvironment (also known as the Warburg effect) is one of the factors preventing immune cells from mounting effective responses and contributing to immunotherapy treatment failure. Therefore, reducing tumor acidity is important for increasing cancer immunotherapy effectiveness and this has yet to be realized in the TNBC environment. In this study, the oral administration of sodium bicarbonate (NaHCO3) enhanced the antitumor effect of anti-PD-L1 antibody treatment, as demonstrated by generated antitumor immunity, tumor growth inhibition and enhanced survival in 4T1-Luc breast cancer model. Here, we show that NaHCO3 increased extracellular pH (pHe) in tumor tissues in vivo, an effect that was accompanied by an increase in T cell infiltration, T cell activation and IFN-γ, IL2 and IL12p40 mRNA expression in tumor tissues, as well as an increase in T cell activation in tumor-draining lymph nodes. Interestingly, these changes were further enhanced in response to combined NaHCO3 + anti-PD-L1 therapy. In addition, the acidic extracellular conditions caused a significant increase in PD-L1 expression in vitro. Taken together, these results indicate that alkalizing therapy holds potential as a new tumor microenvironment immunomodulator and we hypothesize that NaHCO3 can enhance the antitumor effects of anti-PD-L1 breast cancer therapy. The combination of these treatments may have an exceptional impact on future TNBC immunotherapeutic approaches by providing a powerful personalized medicine paradigm. Therefore, our findings have a great translational potential for improving outcomes in TNBC patients.

Schlagwörter

Stichwörter der Autor:innen

PD-L1TNBCextracellular pH (pHe)immunotherapysodium bicarbonate (NaHCO3)

Autor:innen und Institutionen

  • Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Department of Radiation Oncology, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Women's Health Services, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Mohsin Kazi

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Rahman, A., Janic, B., Rahman, T., Singh, H., Ali, H., Rattan, R., Kazi, M., & Ali, M. M. (2023). Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model. Cancers, 15(20), 4931. https://doi.org/10.3390/cancers15204931

Vancouver

Rahman A, Janic B, Rahman T, Singh H, Ali H, Rattan R, et al. Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model. Cancers. 2023;15(20):4931. doi:10.3390/cancers15204931

BibTeX
@article{Rahman2023,
  author = {Rahman, Azizur and Janic, Branislava and Rahman, Tasnim and Singh, Harshit and Ali, Haythem and Rattan, Ramandeep and Kazi, Mohsin and Ali, Meser M},
  title = {Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {20},
  pages = {4931},
  doi = {10.3390/cancers15204931}
}
Kostenlos starten →